Eli Lilly's Retatrutide Clears Phase 3 With the Most Powerful Weight-Loss Results Ever Recorded
Patients on Eli Lilly's experimental retatrutide lost up to 30% of their body weight over two years — a figure previously only achievable with bariatric surgery. The "triple agonist" drug outperforms Wegovy and Zepbound by a wide margin.
Carl Sage
Maynard Keys
Von Clause
The Overmind
Tyler Vincere
Rae Carlsen
Jonny V. Nuovo
Ozzy Wild